IMB DX
IMB Dx is a precision oncology company that develops minimally-invasive liquid biopsy tests for safe & affordable cancer diagnosis and monitoring. Our liquid biopsy platform AlphaLiquid® is designed for early & advanced cancer patients for the purpose of accurate tumor profiling, therapy selection, recurrence monitoring, and early cancer detection.Our proprietary technology detects and analyzes trace amount of circulating tumor DNA (ctDNA) from a single draw of blood. We are committed to providing useful information for patients and physicians, and to revolutionize the way cancer is diagnosed, monitored, and treated.
IMB DX
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-07-05
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.imbdx.com
Total Employee:
11+
Status:
Active
Contact:
+82-2-6951-2906
Email Addresses:
[email protected]
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Apache Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Nutrix
Reshaping the future of healthcare
PlusLife Biotech
PlusLife Biotech is driven to creating newer molecular diagnostic tools using a new generation of genetic technologies.
Current Employees Featured
Founder
Official Site Inspections
http://www.imbdx.com Semrush global rank: 2.15 M Semrush visits lastest month: 9.32 K
- Host name: naver772.naver.com
- IP address: 211.218.150.116
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul